AAAAAA

   
Results: 1-2 |
Results: 2
Tolerability profiles of rofecoxib (Vioxx (R)) and Arthrotoc (R) - A comparison of six weeks treatment in patients with osteoarthritis
Authors: Acevedo, E Castaneda, O Ugaz, M Beaulieu, AD Pons-Estel, B Caeiro, F Casas, N Garza-Elizondo, M Irazoque, F Hinojosa, W Gutierrez-Urena, S Vandormael, K Rodgers, DB Laurenzi, M
Citation: E. Acevedo et al., Tolerability profiles of rofecoxib (Vioxx (R)) and Arthrotoc (R) - A comparison of six weeks treatment in patients with osteoarthritis, SC J RHEUM, 30(1), 2001, pp. 19-24
The tumor-necrosis-factor receptor-associated periodic syndrome: New mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers
Authors: Aksentijevich, I Galon, J Soares, M Mansfield, E Hull, K Oh, HH Goldbach-Mansky, R Dean, J Athreya, B Reginato, AJ Henrickson, M Pons-Estel, B O'Shea, JJ Kastner, DL
Citation: I. Aksentijevich et al., The tumor-necrosis-factor receptor-associated periodic syndrome: New mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers, AM J HU GEN, 69(2), 2001, pp. 301-314
Risultati: 1-2 |